touchPODCAST

touchPODCAST

By touchpodcastScience
Download on the App Store

touchPODCAST episodes

  • Focus on cognitive impairment in the diagnosis and management of relapsing MS - Part 1

    touchMDT for touchNEUROLOGY

    Listen to experts with multidisciplinary perspectives, discuss the importance of early diagnosis of relapsing MS for improved long-term patient outcomes.

    The multidisciplinary team

    • Neurologist/MS specialist: Prof. Mark Freedman, Canada
  • Clinical psychologist/MS educator: Dr Rosalind Kalb, USA

    • This touchPODCAST is for HCPs only. 

    This activity is funded by an unrestricted independent medical education grant from Bristol Myers Squibb. This activity is jointly provided by USF Health and touchIME. 


    For further information visit our website:
    https://touchneurologyime.org/mdt-cognitive-impairment-in-relapsing-ms

    12 min
  • MDT and patient perspectives on the importance of treatment intensification, weight loss, and education in T2D and obesity

    touchMDT for touchENDOCRINOLOGY

    Listen to key experts from a multidisciplinary team and a patient discuss the benefits of early treatment intensification and weight loss for patients with T2D and obesity as well as the importance of effective patient education strategies. 

    The multidisciplinary team and patient

    • Diabetes care & education specialist: Ms Jennifer Okemah, Kirkland, WA
  • Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA
  • Patient: Ms Brittany Jones, Atlanta, GA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchendocrinologyime.org/glycemic-control-weight-loss-in-t2d-obesity-incretin-based-dual-agonists/

    18 min
  • MDT and patient perspectives on GLP-1 RA therapy and emerging incretin-based dual agonists in T2D and obesity

    touchMDT for touchENDOCRINOLOGY

    Listen to key experts from a multidisciplinary team and a patient explore the use of GLP-1 RA therapy to treat T2D and obesity, including observations from a patient’s perspective, and consider the evidence for incretin-based dual agonists in development

    The multidisciplinary team and patient

    • Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA
  • Endocrinologist (obesity): Dr Ken Fujioka, San Diego, CA
  • Patient: Ms Brittany Jones, Atlanta, GA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchendocrinologyime.org/glycemic-control-weight-loss-in-t2d-obesity-incretin-based-dual-agonists/touchENDOCRINOLOGY

    15 min
  • MDT perspectives on the role of incretin hormones in wellness and in T2D

    touchMDT for touchENDOCRINOLOGY

    Listen to key experts from a multidisciplinary team discuss the role of incretin hormones in healthy individuals and in those with T2D and share insights from the latest research in this field 

    The multidisciplinary team

    • Endocrinologist (obesity): Dr Ken Fujioka, San Diego, CA
  • Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This activity is jointly provided by USF Health and touchIME.


    For further information visit: https://touchendocrinologyime.org/glycemic-control-weight-loss-in-t2d-obesity-incretin-based-dual-agonists/

    10 min
  • Targeting the pathobiology of ESCC: Potential impact of immunotherapy on clinical practice

    touchEXPERT OPINIONS for touchONCOLOGY


    Listen to leading experts provide an update on the underlying pathobiology of esophageal squamous cell carcinoma, and review current and emerging therapies.

    The experts

    • Prof. Ken Kato, National Cancer Center Hospital, Tokyo, Japan
  • Dr Jean-Phillippe Metges, Brest University Hospital, Brest, France
  • Dr Radka Obermannova, Masaryk Memorial Cancer Institute Brno, Czech Republic

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from from Novartis. This activity is provided by touchIME.

    For further information visit our website: https://touchoncologyime.org/targeting-pathobio-of-ESCC-and-emerging-impact-of-IO

    34 min
  • The evolving role of antibody–drug conjugates in the treatment of urothelial carcinoma

    Listen to a genitourinary cancer expert outline the use of antibody–drug conjugates in the treatment of urothelial carcinoma, including their place in current treatment guidelines, clinical trial data and the management of possible adverse events.

    The expert

    • Dr Cora Sternberg, Weill Cornell Medicine, New York, NY, USA

    This touchPODCAST is for HCPs only. 

    This activity is funded by an unrestricted independent medical education grant from Gilead Sciences and Seagen. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchoncologyime.org/antibody-drug-conjugates-in-urothelial-carcinoma/

    33 min
  • MDT and patient perspectives on the long-term management of patients with severe type 2 asthma

    touchMDT for touchRESPIRATORY

    Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss evidence-based guidance for the long-term management of patients with severe type 2 asthma. 

    The multidisciplinary team 

    • Pulmonologist: Professor Alberto Papi, Italy
  • Allergist: Professor Ioana Agache, Romania
  • Primary care physician: Professor Barbara Yawn, USA
  • Patient: Ms JoJo O’Neal, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchrespiratoryime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care/

    17 min
  • MDT and patient perspectives on the disease burden of severe asthma

    touchMDT for touchIMMUNOLOGY

    Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss the daily challenges of living with severe asthma for patients and their families.


    The multidisciplinary team

    • Primary care physician: Professor Barbara Yawn, USA
  • Allergist: Professor Ioana Agache, Romania
  • Patient: Ms JoJo O’Neal, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchimmunologyime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care//

    14 min
  • MDT perspectives on biologic treatment selection in severe type 2 asthm

    touchMDT for touchRESPIRATORY

    Listen to key experts from a multidisciplinary team explore the use of endotyping and biomarkers in guiding biologic treatment selection for patients with severe type 2 asthma.

    The multidisciplinary team 

    • Allergist: Professor Ioana Agache, Romania
  • Primary care physician: Professor Barbara Yawn, USA
  • Pulmonologist: Professor Alberto Papi, Italy

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchrespiratoryime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care/

    17 min
  • MDT and patient perspectives on the disease burden of severe asthma

    touchMDT for touchRESPIRATORY

    Listen to key experts from a multidisciplinary team, and a patient with severe asthma, discuss the daily challenges of living with severe asthma for patients and their families.

    The multidisciplinary team

    • Primary care physician: Professor Barbara Yawn, USA
  • Allergist: Professor Ioana Agache, Romania
  • Patient: Ms JoJo O’Neal, USA

    • This touchPODCAST is for HCPs only.

    This activity is funded by an unrestricted independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME.

    For further information visit our website: https://touchrespiratoryime.org/strategies-for-the-management-of-severe-type-2-asthma-expert-insight-into-optimizing-care/

    14 min

About touchPODCAST

From the publisher's feed

Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites.